Page 77 - 2021 Taiwan Food and Drug Administration Annual Report
P. 77

Ch6 Special planning

    2020 was the year for the nation to unite         Introduction of the Policy
as one to fight against severe acute respi-
ratory infection (hereinafter referred to as              In response to the outbreak of the
COVID-19) pandemic. Under the leadership              &29,'     SDQGHPLF   7)'$  KDV  SUHSDUHG  D 
of the “Severe Acute Respiratory Infection            QXPEHU RI FRQWLQJHQF\ PHDVXUHV  VXFK DV SUR-
&HQWUDO  (SLGHPLF  &RPPDQG  &HQWHU´   KHUH-           DFWLYH  LQYHQWRU\  RI  GUXJV   IRUPXODWLRQ  RI  UHO-
LQDIWHU  UHIHUUHG  WR  DV  WKH  &RPPDQG  &HQWHU       HYDQW  PDQDJHPHQW  SULQFLSOHV   SULRULW\  UHYLHZ 
various agencies collaborated together to             RI $3,  UHODWHG  DSSOLFDWLRQV   DQG  DFFHOHUDWHG 
organize various pandemic control materials           UHYLHZ RI SDQGHPLF FRQWURO GUXJV  LQ RUGHU WR 
and supplies in advance. The Agency was               prevent the disorder of domestic drug supply
UHVSRQVLEOH  IRU  PDQDJLQJ  PHGLFDO  SURGXFWV         and protect the rights and interests of citizens
VXFFHVVIXOO\ SURYLGLQJ VXSSOLHV WR WKH H൵RUWV         using drugs and receiving treatment. There are
of pandemic control.                                  relevant counseling measures to continuously
                                                      track the status of research and development
    In order to illustrate the results of the         RI GUXJV DQG YDFFLQHV DW KRPH DQG DEURDG  DQG 
$JHQF\¶V  HIIRUWV  LQ  SDQGHPLF  FRQWURO   WKLV       KHOS DFFHOHUDWH WKH 5	' DQG PDUNHW ODXQFK RI 
chapter fully presents the preparation of pan-        therapeutic drugs and vaccines.
GHPLF  FRQWURO  GUXJV   YDFFLQHV   DQG  PHGLFDO 
GHYLFHV   DV  ZHOO  DV  WKH  GLVWULEXWLRQ  SODQ  RI   Implementation Strategy
UHDO QDPH UHJLVWUDWLRQ V\VWHP     IRU PDVNV  
LQFOXGLQJ  FRRUGLQDWLQJ  VXSSO\  DQG  GHPDQG          I. Reinforced drug management
accelerating review and proactive counsel-              during the pandemic control
LQJ   DQG  IDFLOLWDWLQJ  SURPRWLRQ  7KH  MRLQW          period
H൵RUWV RI WKH SXEOLF DQG SULYDWH VHFWRUV  ODLG 
the foundation for pandemic control.                   ,  6 L Q F H   ) H E U X D U \               7 ) ' $  K D V 
                                                          prioritized accelerating the review
Section 1                                                 of changes in the source of active
                                                          SKDUPDFHXWLFDO  LQJUHGLHQWV   LPSRUWLQJ 
Drug Management and                                       RI  UDZ  PDWHULDOV  IRU  VHOI XVH   HWF    DQG  DW 
Pandemic Control Actions                                  WKH  VDPH  WLPH   ZH  DOVR  HQFRXUDJHG  WKH 
                                                          industry to look for alternative sources
                                                          of active pharmaceutical ingredients in

                                                                                                               75
   72   73   74   75   76   77   78   79   80   81   82